Xuan Zhang

Xuan Zhang serves as an External Researcher in the Department of Economics at Singapore Management University (SMU), with physical operations based at the University of Copenhagen's Department of Economics (Øster Farimagsgade 5, Bygning 26, 1353 København K). International collaboration patterns span multiple countries as visualized in research network maps, reflecting globally distributed scholarly engagement despite the Singapore email affiliation (xuanzhang@smu.edu.sg).

Research integrates Economics with cutting-edge biomedical science, prioritizing Health Economics and Cancer Research. The interdisciplinary approach bridges economic analysis with molecular immunology, evidenced by high-impact work on tumor microenvironment modulation. Specific expertise includes translating economic frameworks to biomedical innovation assessment and therapeutic development pathways, particularly in oncology-focused health technology evaluation.

Recent publications demonstrate focused contributions in proteolysis-targeting chimera applications, with the 2021 Nature Communications article establishing Zhang's role in developing BCL-XL-targeted therapies to eliminate immunosuppressive regulatory T cells in tumors. This work intersects cancer immunotherapy, molecular degradation techniques, and health economics, indicating a trajectory toward economically viable biomedical solutions with strong translational potential.